These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18327222)

  • 61. US law threatens flow of foreign capital to biotech sector.
    Morrison C
    Nat Biotechnol; 2018 Oct; 36(10):914-915. PubMed ID: 30307931
    [No Abstract]   [Full Text] [Related]  

  • 62. When will the bear move on? The current problems of the biotechnology industry are not solely a reflection of the whole market but are also caused by some specific problems.
    Brower V
    EMBO Rep; 2002 Nov; 3(11):1015-7. PubMed ID: 12429609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HHS: POUFA reauthorization good for Americans.
    FDA Consum; 2002; 36(5):5. PubMed ID: 12412536
    [No Abstract]   [Full Text] [Related]  

  • 64. New IGF drug stirs competition in growth factor segment.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
    [No Abstract]   [Full Text] [Related]  

  • 65. Sustaining agbiotechnology through lean times.
    McElroy D
    Nat Biotechnol; 2003 Sep; 21(9):996-1002. PubMed ID: 12949560
    [No Abstract]   [Full Text] [Related]  

  • 66. Biotech business Down Under.
    Beckley C
    Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
    [No Abstract]   [Full Text] [Related]  

  • 67. Beyond the lab in biotech. With so many drugs in trial, new jobs are opening up.
    Carmichael M
    Newsweek; 2002 Sep; 140(13):53. PubMed ID: 12375414
    [No Abstract]   [Full Text] [Related]  

  • 68. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Capital faucet wide-open. Firms' healthcare-related investments up 16% in first half.
    Pallarito K
    Mod Healthc; 1997 Sep; 27(35):76. PubMed ID: 10170390
    [No Abstract]   [Full Text] [Related]  

  • 70. Investor Outlook: After the Biotech Bubble Popped.
    Schimmer J; Breazzano S; Yang J
    Hum Gene Ther Clin Dev; 2016 Mar; 27(1):19-26. PubMed ID: 26981952
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 72. Biotech blockbusters consolidate markets.
    Lawrence S
    Nat Biotechnol; 2006 Dec; 24(12):1466. PubMed ID: 17160033
    [No Abstract]   [Full Text] [Related]  

  • 73. Angel investors shy away from biotech.
    Bouchie A
    Nat Biotechnol; 2005 Jan; 23(1):145. PubMed ID: 15706637
    [No Abstract]   [Full Text] [Related]  

  • 74. Lack of private financing hobbles emerging biotech regions.
    Jia H; Jayarama KS; Astvatsaturyan M
    Nat Biotechnol; 2006 Jan; 24(1):7-9. PubMed ID: 16404378
    [No Abstract]   [Full Text] [Related]  

  • 75. Biotech round the world: focus on Canada.
    Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
    [No Abstract]   [Full Text] [Related]  

  • 76. Caveat investor.
    Nature; 1998 May; 393(6683):291. PubMed ID: 9620784
    [No Abstract]   [Full Text] [Related]  

  • 77. User fees hold up EU agency for drug approvals.
    Ward M
    Biotechnology (N Y); 1995 Mar; 13(3):213. PubMed ID: 9678939
    [No Abstract]   [Full Text] [Related]  

  • 78. European markets target foreign biotechs.
    Louët S
    Nat Biotechnol; 2003 Jul; 21(7):719. PubMed ID: 12833075
    [No Abstract]   [Full Text] [Related]  

  • 79. IPO floodgates unlikely to open after Ark floatation.
    Louët S
    Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538
    [No Abstract]   [Full Text] [Related]  

  • 80. Biotech boom prompts fears of bust.
    Ledford H
    Nature; 2013 Aug; 500(7464):513. PubMed ID: 23985852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.